The Asia Pacific Antimicrobial Resistance Diagnostics Market would witness market growth of 7.1% CAGR during the forecast period (2022-2028).
The use of antibiotics in the management of chronic diseases such as diabetes, rheumatoid arthritis, and asthma as well as organ transplants, joint replacements, and cancer therapy all depend on this ability. Sometimes there is no cure for certain infections. Healthcare professionals would no longer be capable of treating infections and managing these risks to public health if antifungals and antibiotics lost their effectiveness.
Diagnostics enable the right use of novel medications when they are brought into medical care all through their commercial lifecycle. It is crucial for medical professionals and treating doctors to know patient-specific beneficial treatments. Similarly, it is crucial for antimicrobial stewardship boards to know how to fulfil the needs of all patients at the institutions with regard to resistance. Even if a drug were available and capable of saving patients' lives, it might not be taken at all or be misused without a diagnostic tool that can determine if a patient will likely benefit from it.
As it restricts the access of patients and settings to antimicrobials to only those situations in which the medications are likely to enhance an individual's health condition, appropriate usage is fundamental in the control of antimicrobial resistance. The likelihood that a drug's effectiveness will decrease owing to resistance increases the more inadequately antimicrobials are used. Diagnostics aid the medical community in maintaining the usefulness of these priceless medications due to the enormous number of resources and time needed to identify new effective and safe antibiotics.
Several patients in India can no longer receive an advantage from carbapenem, a potent antibiotic used mostly in intensive care units to treat pneumonia and septicemia since they have grown resistant to it. This was stated in research by the Indian Council of Medical Research (ICMR). This is concerning since AMR, is on the increase in India and still poses a serious threat to public health in terms of death and monetary loss. The Indian government recognized the importance of rapid tests that provide timely and accurate diagnoses and can shorten the time it takes to identify the infection and enable more effective antibiotic therapy. A need for POC diagnostic tests to direct antibiotic prescriptions, in both rural and urban settings.
The China market dominated the Asia Pacific Antimicrobial Resistance Diagnostics Market by Country in 2021; thereby, achieving a market value of $413.4 million by 2028. The Japan market is registering a CAGR of 6.5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 7.8% during (2022 - 2028).
Based on Technology, the market is segmented into PCR, Immunoassay, NGS, Microbiology Culture, Mass Spectrometry, Rapid & Point of Care and Others. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Pharmaceutical, Biotechnology Companies & Others. Based on Pathogen, the market is segmented into Methicillin Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile (CD), Drug Resistant Campylobacter (DRC), Drug Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRNTS) and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Antimicrobial Resistance Diagnostics Market is Projected to reach USD 5.7 Billion by 2028, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Danaher Corporation, Accelerate Diagnostics, Inc., Hologic, Inc., Visby Medical, Inc., Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd) and Molsid S.A.S.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- PCR
- Immunoassay
- NGS
- Microbiology Culture
- Mass Spectrometry
- Rapid & Point of Care
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical, Biotechnology Companies & Others
By Pathogen
- Methicillin Resistant Staphylococcus Aureus (MRSA)
- Clostridium Difficile (CD)
- Drug Resistant Campylobacter (DRC)
- Drug Resistant Streptococcus Pneumoniae (DRSP)
- Drug Resistant Neisseria Gonorrhoeae (DRNG)
- Drug Resistant Salmonella (DRNTS)
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- BioMérieux S.A.
- F.Hoffmann-La Roche Ltd.
- Becton, Dickinson and Company
- Danaher Corporation
- Accelerate Diagnostics, Inc.
- Hologic, Inc.
- Visby Medical, Inc.
- Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
- Molsid S.A.S.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Antimicrobial Resistance Diagnostics Market, by Technology
1.4.2 Asia Pacific Antimicrobial Resistance Diagnostics Market, by End User
1.4.3 Asia Pacific Antimicrobial Resistance Diagnostics Market, by Pathogen
1.4.4 Asia Pacific Antimicrobial Resistance Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology
4.1 Asia Pacific PCR Market by Country
4.2 Asia Pacific Immunoassay Market by Country
4.3 Asia Pacific NGS Market by Country
4.4 Asia Pacific Microbiology Culture Market by Country
4.5 Asia Pacific Mass Spectrometry Market by Country
4.6 Asia Pacific Rapid & Point of Care Market by Country
4.7 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Diagnostic Laboratories Market by Country
5.3 Asia Pacific Pharmaceutical, Biotechnology Companies & Others Market by Country
Chapter 6. Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen
6.1 Asia Pacific Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
6.2 Asia Pacific Clostridium Difficile (CD) Market by Country
6.3 Asia Pacific Drug Resistant Campylobacter (DRC) Market by Country
6.4 Asia Pacific Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
6.5 Asia Pacific Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
6.6 Asia Pacific Drug Resistant Salmonella (DRNTS) Market by Country
6.7 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Antimicrobial Resistance Diagnostics Market by Country
7.1 China Antimicrobial Resistance Diagnostics Market
7.1.1 China Antimicrobial Resistance Diagnostics Market by Technology
7.1.2 China Antimicrobial Resistance Diagnostics Market by End-user
7.1.3 China Antimicrobial Resistance Diagnostics Market by Pathogen
7.2 Japan Antimicrobial Resistance Diagnostics Market
7.2.1 Japan Antimicrobial Resistance Diagnostics Market by Technology
7.2.2 Japan Antimicrobial Resistance Diagnostics Market by End-user
7.2.3 Japan Antimicrobial Resistance Diagnostics Market by Pathogen
7.3 India Antimicrobial Resistance Diagnostics Market
7.3.1 India Antimicrobial Resistance Diagnostics Market by Technology
7.3.2 India Antimicrobial Resistance Diagnostics Market by End-user
7.3.3 India Antimicrobial Resistance Diagnostics Market by Pathogen
7.4 South Korea Antimicrobial Resistance Diagnostics Market
7.4.1 South Korea Antimicrobial Resistance Diagnostics Market by Technology
7.4.2 South Korea Antimicrobial Resistance Diagnostics Market by End-user
7.4.3 South Korea Antimicrobial Resistance Diagnostics Market by Pathogen
7.5 Singapore Antimicrobial Resistance Diagnostics Market
7.5.1 Singapore Antimicrobial Resistance Diagnostics Market by Technology
7.5.2 Singapore Antimicrobial Resistance Diagnostics Market by End-user
7.5.3 Singapore Antimicrobial Resistance Diagnostics Market by Pathogen
7.6 Malaysia Antimicrobial Resistance Diagnostics Market
7.6.1 Malaysia Antimicrobial Resistance Diagnostics Market by Technology
7.6.2 Malaysia Antimicrobial Resistance Diagnostics Market by End-user
7.6.3 Malaysia Antimicrobial Resistance Diagnostics Market by Pathogen
7.7 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market
7.7.1 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology
7.7.2 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user
7.7.3 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 BioMérieux S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition, Joint Ventures and Mergers:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Danaher Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Acquisition and Mergers:
8.6 Hologic, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Financial Analysis
8.6.4 Segmental and Regional Analysis
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Acquisition and Mergers:
8.7 Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Molsid SAS
8.8.1 Company Overview
8.9 Visby Medical, Inc.
8.9.1 Company Overview
8.10. Accelerated Technology Laboratories, Inc.
8.10.1 Company Overview
TABLE 1 Asia Pacific Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antimicrobial Resistance Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Antimicrobial Resistance Diagnostics Market
TABLE 5 Acquisition and Mergers– Antimicrobial Resistance Diagnostics Market
TABLE 6 Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 7 Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 8 Asia Pacific PCR Market by Country, 2018 - 2021, USD Million
TABLE 9 Asia Pacific PCR Market by Country, 2022 - 2028, USD Million
TABLE 10 Asia Pacific Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 11 Asia Pacific Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 12 Asia Pacific NGS Market by Country, 2018 - 2021, USD Million
TABLE 13 Asia Pacific NGS Market by Country, 2022 - 2028, USD Million
TABLE 14 Asia Pacific Microbiology Culture Market by Country, 2018 - 2021, USD Million
TABLE 15 Asia Pacific Microbiology Culture Market by Country, 2022 - 2028, USD Million
TABLE 16 Asia Pacific Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 17 Asia Pacific Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 18 Asia Pacific Rapid & Point of Care Market by Country, 2018 - 2021, USD Million
TABLE 19 Asia Pacific Rapid & Point of Care Market by Country, 2022 - 2028, USD Million
TABLE 20 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 21 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 22 Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 23 Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 24 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 25 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 26 Asia Pacific Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 27 Asia Pacific Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 28 Asia Pacific Pharmaceutical, Biotechnology Companies & Others Market by Country, 2018 - 2021, USD Million
TABLE 29 Asia Pacific Pharmaceutical, Biotechnology Companies & Others Market by Country, 2022 - 2028, USD Million
TABLE 30 Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 31 Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 32 Asia Pacific Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2018 - 2021, USD Million
TABLE 33 Asia Pacific Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2022 - 2028, USD Million
TABLE 34 Asia Pacific Clostridium Difficile (CD) Market by Country, 2018 - 2021, USD Million
TABLE 35 Asia Pacific Clostridium Difficile (CD) Market by Country, 2022 - 2028, USD Million
TABLE 36 Asia Pacific Drug Resistant Campylobacter (DRC) Market by Country, 2018 - 2021, USD Million
TABLE 37 Asia Pacific Drug Resistant Campylobacter (DRC) Market by Country, 2022 - 2028, USD Million
TABLE 38 Asia Pacific Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2018 - 2021, USD Million
TABLE 39 Asia Pacific Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2022 - 2028, USD Million
TABLE 40 Asia Pacific Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2018 - 2021, USD Million
TABLE 41 Asia Pacific Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2022 - 2028, USD Million
TABLE 42 Asia Pacific Drug Resistant Salmonella (DRNTS) Market by Country, 2018 - 2021, USD Million
TABLE 43 Asia Pacific Drug Resistant Salmonella (DRNTS) Market by Country, 2022 - 2028, USD Million
TABLE 44 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 45 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 46 Asia Pacific Antimicrobial Resistance Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 47 Asia Pacific Antimicrobial Resistance Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 48 China Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 49 China Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 50 China Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 51 China Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 52 China Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 53 China Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 54 China Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 55 China Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 56 Japan Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 57 Japan Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 58 Japan Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 59 Japan Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 60 Japan Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 61 Japan Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 62 Japan Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 63 Japan Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 64 India Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 65 India Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 66 India Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 67 India Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 68 India Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 69 India Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 70 India Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 71 India Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 72 South Korea Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 73 South Korea Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 74 South Korea Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 75 South Korea Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 76 South Korea Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 77 South Korea Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 78 South Korea Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 79 South Korea Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 80 Singapore Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 81 Singapore Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 82 Singapore Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 83 Singapore Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 84 Singapore Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 85 Singapore Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 86 Singapore Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 87 Singapore Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 88 Malaysia Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 89 Malaysia Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 90 Malaysia Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 91 Malaysia Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 92 Malaysia Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 93 Malaysia Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 94 Malaysia Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 95 Malaysia Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 96 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 97 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 98 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 99 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 100 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 101 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 102 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 103 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 104 Key Information – Abbott Laboratories
TABLE 105 Key information – Becton, Dickinson and Company
TABLE 106 Key information – BioMérieux S.A.
TABLE 107 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 108 Key Information – Danaher Corporation
TABLE 109 Key information – Hologic, Inc.
TABLE 110 Key Information – Vela Diagnostics Pte. Ltd.
TABLE 111 Key Information – Molsid SAS
TABLE 112 Key Information – Visby Medical, Inc.
TABLE 113 key information – Accelerated Technology Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Swot analysis: Abbott laboratories
FIG 5 Recent strategies and developments: BioMérieux S.A.
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.